NY S05439 | 2023-2024 | General Assembly
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on March 6 2023 - 25% progression
Action: 2024-01-03 - REFERRED TO HEALTH
Pending: Senate Health Committee
Text: Latest bill text (Amended) [HTML]
Status: Introduced on March 6 2023 - 25% progression
Action: 2024-01-03 - REFERRED TO HEALTH
Pending: Senate Health Committee
Text: Latest bill text (Amended) [HTML]
Summary
Designates Xylazine as a schedule III depressant.
Title
Designates Xylazine as a schedule III depressant.
Sponsors
History
Date | Chamber | Action |
---|---|---|
2024-01-03 | Senate | REFERRED TO HEALTH |
2023-11-01 | Senate | PRINT NUMBER 5439A |
2023-11-01 | Senate | AMEND AND RECOMMIT TO HEALTH |
2023-03-06 | Senate | REFERRED TO HEALTH |
Same As/Similar To
A05914 (Same As) 2024-01-03 - referred to health